The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan

NCT01238588 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped The study stopped due to lack of funding.

Conditions

Dialysis
Cardiovascular Disease
Atherosclerosis
Inflammation
Hyperphosphatemia

Interventions

DRUG: Sevelamer Carbonate (Renvela)

Sponsor

Brigham and Women's Hospital